Key Pharmacy Recalls Sterile Ophthalmic Compounded Drug Due to Sterility Concerns
Key Pharmacy and Compounding Center is recalling a specific lot of sterile compounded ophthalmic drug due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in a sterile compounded drug, which poses a significant risk of infection or serious injury.
Plain-English summary
Key Pharmacy and Compounding Center is recalling a specific lot of VIT C/GSH 1.25%-1.25% OPHTH, a sterile compounded ophthalmic drug. The product is a prescription-only, 15 mL plastic multiple-dose bottle prepared by the firm. The recall is being conducted due to a lack of assurance of sterility for the sterile compounded drugs within their expiry date.
The affected product is identified by Lot # 02-23-2017@35 with an expiration date of 4/24/2017. The source text indicates that the product was distributed nationwide in the U.S.A., as well as in Australia and Canada. The source text does not specify the number of units affected or report any illnesses or injuries associated with the product.
Consumers and healthcare providers should check their inventory for the specific lot number and expiration date listed above. If the product matches the recalled lot, it should be discontinued from use and returned to the pharmacy or disposed of according to local regulations. The source text does not provide specific contact information for the recalling firm or instructions for disposal.
The recalled product
- Product
- VIT C/GSH 1.25%-1.25% OPHTH, Ophthalmic, 1.25%, Rx only, 15 mL Plastic/ Multiple Dose bottle, Prepared by Key Compounding Pharmacy
- Manufacturer
- Key Pharmacy and Compounding Center
- Category
- Drug — Compounded Sterile Drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 02-23-2017@35
- Exp 4/24/2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 79 recalled by Key Pharmacy and Compounding Center under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 79 products in this recall →Related recalls
Same manufacturer · Key Pharmacy and Compounding Center
See all →- SevereKey Pharmacy Recalls Pyridoxal-5-Phosphate Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls Sterile Compounded Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- HighKey Pharmacy Recalls Vitamin D3 Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls 5-MTHF Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls Folic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereCyclopentolate HCL Ophthalmic Recall Due to Sterility Concerns
FDA (Drugs) · 2014-01-22
- SevereUS Compounding Recalls Acetylcysteine 10% Ophthalmic Solution for Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereUS Compounding Recalls Phenylephrine Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereUS Compounding Recalls Pilocarpine Ophthalmic Drops Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereSpecialty Medicine Compounding Pharmacy Recalls Ceftazidime Ophthalmic Solution
FDA (Drugs) · 2014-01-22
- SevereGatifloxacin Ophthalmic Drops Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2014-01-22